COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 305: Articles 3041-3050  | Next

Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review
Agarwal, A., Panjiyar, B. K., Patel, D. M., Ghotra, M., Husain, M. G. N., Upadhyay, R. B.
10.1101/2023.09.05.23295067 — Posted: 2023-09-05
Psychotherapies and Psychological Support for Individuals Facing Psychological Distress during the COVID-19 Pandemic: A Scoping Review
Yagihashi, M., Sakuma, A., Murakami, M.
10.1101/2023.09.04.23295013 — Posted: 2023-09-05
Correlation of myeloid-derived suppressor cell expansion with upregulated transposable elements in severe COVID-19 unveiled in single-cell RNA sequencing reanalysis
Farahmandnejad, M., Mosadeghi, P., Dorvash, M., Sakhteman, A., Faridi, P., Negahdaripour, M.
10.1101/2023.09.04.556192 — Posted: 2023-09-05
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86
Lasrado, N., Collier, A.-r., Hachmann, N., Miller, J., Rowe, M., Schonberg, E., Rodrigues, S., LaPiana, A., Patio, R., Anand, T., Fisher, J., Mazurek, C., Guan, R., Wagh, K., Theiler, J., Korber, B., Barouch, D. H.
10.1101/2023.09.04.556272 — Posted: 2023-09-05
Deep unsupervised learning methods for the identification and characterization of TCR specificity to Sars-Cov-2
Miraoui, Y. N.
10.1101/2023.09.05.556326 — Posted: 2023-09-05
COVID-19 vaccines and autoimmune disorders: A scoping review protocol
Chaufan, C., Manwell, L., Heredia, C., McDonald, J.
10.1101/2023.09.03.23295001 — Posted: 2023-09-04
Neutralization of SARS-CoV-2 EG.5/EG.5.1 by sera from ZF2001 RBD-dimer and its next-generation vaccines
An, Y., Zhou, X., Tao, L., Xie, H., Yang, C., Li, D., Wang, R., Hu, H., Liu, K., Dai, L., Xu, K., Gao, G. F.
10.1101/2023.09.02.556038 — Posted: 2023-09-04
Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86
Yang, S., Yu, Y., Jian, F., Song, W., Yisimayi, A., Chen, X., Xu, Y., Wang, P., Yu, L., Wang, J., Niu, X., Wang, J., Xiao, T., An, R., Wang, Y., Gu, Q., Shao, F., Jin, R., Shen, Z., Wang, Y., Cao, Y. R.
10.1101/2023.09.01.555815 — Posted: 2023-09-04
Meisoindigo: An Effective Inhibitor of SARS-CoV-2 Main Protease Revealed by Yeast System
Grabinski, W., Kicinska, A., Kosicka, E., Baranek-Grabinska, M., Hejenkowska, E. D., Budzik, J., Sliska, P., Sliwinska, W., Karachitos, A.
10.1101/2023.09.03.555867 — Posted: 2023-09-04
Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Sheward, D. J., Yang, Y., Westerberg, M., Öling, S., Muschiol, S., Sato, K., Peacock, T. P., Karlsson Hedestam, G. B., Albert, J., Murrell, B.
10.1101/2023.09.02.556033 — Posted: 2023-09-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).